Analyst Consensus ?
ConsensusHold41 ratings
Bullish1946.3%
Neutral2048.8%
Bearish24.9%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Bristol-Myers Squibb Company analyst ratings
Bristol-Myers Squibb Company (BMY) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$63.64Current
$37Low
$64.19Average
$92High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 12, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| HSBC | Hold | Hold | Maintain | Sep 10, 2026 |
| Argus Research | Buy | Hold | Upgrade | Aug 5, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 31, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 31, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 31, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 31, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 31, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 10, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 23, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Jan 13, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Jan 9, 2026 |
| UBS | Buy | Neutral | Upgrade | Jan 7, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Dec 12, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Dec 2, 2025 |
| Jefferies | Buy | Buy | Maintain | Apr 23, 2025 |
| BMO Capital | Market Perform | Market Perform | Maintain | Nov 12, 2024 |
| TD Cowen | Hold | Hold | Maintain | Oct 7, 2024 |
| Barclays | Underweight | Underweight | Maintain | Oct 7, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 23, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Feb 6, 2024 |
| Daiwa Capital | Neutral | Outperform | Downgrade | Nov 2, 2023 |
| William Blair | Market Perform | Outperform | Downgrade | Oct 27, 2023 |
| Atlantic Equities | Overweight | Overweight | Maintain | Jul 28, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 28, 2023 |
| Berenberg | Hold | Buy | Downgrade | Sep 14, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Jun 6, 2022 |
| Mizuho | Buy | Buy | Maintain | Nov 17, 2020 |
| Societe Generale | Buy | Hold | Upgrade | Nov 16, 2020 |
| CFRA | Buy | Buy | Maintain | May 7, 2020 |
| Gabelli & Co. | Buy | Buy | Maintain | Nov 27, 2019 |
| Bank of America | Neutral | Neutral | Maintain | Oct 10, 2019 |
| Wolfe Research | Outperform | Outperform | Maintain | Oct 24, 2018 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| DZ Bank | Hold | Buy | Downgrade | Feb 28, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Feb 6, 2018 |
| Hilliard Lyons | Neutral | Upgrade | Oct 28, 2016 | |
| PiperJaffray | Hold | Underperform | Upgrade | Aug 24, 2015 |
| Bernstein | Market Perform | Market Perform | Maintain | May 15, 2014 |
| Cowen & Co. | Outperform | Outperform | Maintain | May 14, 2014 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 29, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $63.64. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| HSBC | Analyst unavailable | $65 | $64.41 | +2.1% | Sep 10, 2026 |
| Roth Capital | Analyst unavailable | $75 | $63.47 | +17.9% | Aug 5, 2026 |
| Argus Research | Jasper Hellweg | $75 | $65.89 | +17.9% | Aug 5, 2026 |
| RBC Capital | Trung Huynh | $64 | $64.73 | +0.6% | Aug 4, 2026 |
| Cantor Fitzgerald | Carter Gould | $59 | $63.67 | -7.3% | Jul 31, 2026 |
| Guggenheim | Seamus Fernandez | $75 | $64.86 | +17.9% | Jul 31, 2026 |
| Wells Fargo | Analyst unavailable | $65 | $64.86 | +2.1% | Jul 31, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $54 | $59.2 | -15.1% | Apr 8, 2026 |
| UBS | Michael Yee | $70 | $59.78 | +10.0% | Mar 6, 2026 |
| RBC Capital | Trung Huynh | $60 | $61.6 | -5.7% | Feb 24, 2026 |
| Piper Sandler | Analyst unavailable | $75 | $60.66 | +17.9% | Feb 23, 2026 |
| Barclays | Analyst unavailable | $75 | $60.3 | +17.9% | Feb 19, 2026 |
| Morgan Stanley | Terence Flynn | $40 | $61.86 | -37.1% | Feb 6, 2026 |
| Guggenheim | Analyst unavailable | $72 | $59.52 | +13.1% | Feb 6, 2026 |
| Wells Fargo | Mohit Bansal | $60 | $59.52 | -5.7% | Feb 6, 2026 |
| Piper Sandler | Analyst unavailable | $66 | $55.56 | +3.7% | Jan 28, 2026 |
| Leerink Partners | David Risinger | $60 | $56.39 | -5.7% | Jan 13, 2026 |
| Scotiabank | Louise Chen | $60 | $55.86 | -5.7% | Jan 9, 2026 |
| UBS | Analyst unavailable | $65 | $56.42 | +2.1% | Jan 7, 2026 |
| Morgan Stanley | Analyst unavailable | $37 | $52.63 | -41.9% | Dec 12, 2025 |
| Guggenheim | Analyst unavailable | $62 | $51.2 | -2.6% | Dec 12, 2025 |
| HSBC | Analyst unavailable | $53 | $50.68 | -16.7% | Dec 10, 2025 |
| Scotiabank | Louis Chen | $53 | $50.96 | -16.7% | Dec 4, 2025 |
| Truist Financial | Srikripa Devarakonda | $65 | $50.98 | +2.1% | Dec 3, 2025 |
| Daiwa | Narumi Nakagiri | $42 | $45.85 | -34.0% | Aug 5, 2025 |
| Truist Financial | David Macdonald | $84 | $47.12 | +32.0% | Jul 21, 2025 |
| Jefferies | Akash Tewari | $68 | $48.52 | +6.9% | Apr 23, 2025 |
| Piper Sandler | David Amsellem | $65 | $49.82 | +2.1% | Apr 22, 2025 |
| BMO Capital | Evan Seigerman | $61 | $56.22 | -4.1% | Nov 12, 2024 |
| BMO Capital | Evan David Seigerman | $57 | $54.32 | -10.4% | Nov 1, 2024 |
| BMO Capital | Evan David Seigerman | $48 | $49.56 | -24.6% | Sep 23, 2024 |
| Goldman Sachs | Chris Shibutani | $57 | $50.54 | -10.4% | Jul 29, 2024 |
| Barclays | Carter Gould | $41 | $50.45 | -35.6% | Jul 29, 2024 |
| UBS | Trung Huynh | $43 | $40.68 | -32.4% | Jul 12, 2024 |
| Cowen & Co. | Steve Scala | $67 | $44.11 | +5.3% | May 16, 2024 |
| Deutsche Bank | James Shin | $55 | $49.87 | -13.6% | Jan 30, 2024 |
| BMO Capital | Evan Seigerman | $60 | $49.76 | -5.7% | Nov 27, 2023 |
| Leerink Partners | David Risinger | $66 | $56.24 | +3.7% | Oct 12, 2023 |
| Cantor Fitzgerald | Louise Chen | $75 | $59.67 | +17.9% | Sep 6, 2023 |
| Wells Fargo | Mohit Bansal | $70 | $78.22 | +10.0% | May 18, 2022 |
| BMO Capital | Analyst unavailable | $92 | $75.66 | +44.6% | May 2, 2022 |
| Barclays | Analyst unavailable | $68 | $75.27 | +6.9% | May 2, 2022 |
| Guggenheim | Seamus Fernandez | $80 | $75.27 | +25.7% | May 2, 2022 |
| BMO Capital | Evan Seigerman | $87 | $75.08 | +36.7% | May 2, 2022 |
| Morgan Stanley | Terence Flynn | $64 | $76.5 | +0.6% | Apr 11, 2022 |
| BMO Capital | Evan Seigerman | $81 | $73.79 | +27.3% | Apr 4, 2022 |
| Morgan Stanley | Matthew Harrison | $66 | $73.11 | +3.7% | Mar 28, 2022 |
| BMO Capital | Evan David Seigerman | $74 | $70.52 | +16.3% | Mar 17, 2022 |
| Barclays | Carter Gould | $66 | $56.22 | +3.7% | Oct 28, 2021 |
| Citigroup | Andrew Baum | $75 | $56.89 | +17.9% | Oct 25, 2021 |
| Guggenheim | Seamus Fernandez | $82 | $59.05 | +28.8% | Sep 20, 2021 |
| Societe Generale | Justin Smith | $85 | $63.63 | +33.6% | Sep 7, 2021 |
| Bank of America Securities | Geoff Meacham | $78 | $65.88 | +22.6% | Jul 27, 2021 |
Track every rating change on BMY the moment it posts. Free to start.
Start free